The reconstitution of gynecologic cancer microenvirnment-making a new therapy

The reconstitution of gynecologic cancer microenvirnment-making a new therapy - Reconstitution of gynecologic cancer microenvirnment

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015608

Enrollment

150

Registered

2014-11-07

Start date

2014-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic cancer

Interventions

Growth inhibiting effect of cancer cells Growth inhibiting effect of cancer tissues

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: To get enough volume of cancer tissue

Exclusion criteria

Exclusion criteria: Tumor tissue is too small to make correct pathological diagnosis.

Design outcomes

Primary

Measure	Time frame
To find out the best combination of drugs that is effective for the treatment of gynecologic cancer. To find out the cell that positioned near cancer cells and make them more malignant.	—

Secondary

Measure	Time frame
engraftment rate analogy of HE stain histopathology	—

Countries

Japan

Contacts

Public ContactTakuya Murata

Kawasaki Medical School Obstetrics and gynecology

tmurata@med.kawasaki-m.ac.jp086-232-8343

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026